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Abstract—Depression and anxiety are common comorbid disorders observed in patients with inﬂammatory bowel
disease (IBD). Increasing line of evidence indicates that immune-inﬂammatory responses are involved in co-
occurrence of mood disorders and IBD. However, the mechanisms through which immune-inﬂammatory path-
ways modulate this comorbidity are not yet understood. This study investigated the role of innate immunity in
the development of behavioral abnormalities associated with an animal model of Crohn’s disease (CD). To do this,
we induced colitis in male adult mice by intrarectal (i.r.) injection of DNBS (Dinitrobenzene sulfonic acid). After 3
days, we performed behavioral tests for anxiety- and depressive-like behaviors as well as tissue collection. Our
results showed that DNBS-induced colonic inﬂammatory responses were accompanied by inﬁltration of inﬂam-
matory cells, and increased expression of genes involved in toll-like receptor signaling pathway in intestinal tis-
sue. Furthermore, the DNBS-treated mice showed depressive- and anxiety-like behaviors which were associated
with increased expression of the inﬂammatory genes and abnormal mitochondrial function in the hippocampus.
These results suggest that peripheral inﬂammation is able to increase the transcriptional level of the genes in toll-
like receptor pathway, induces abnormal mitochondrial function in the hippocampus, and these negative eﬀects
may be involved in the co-occurrence of anxiety and depression in early stages of CD.  2017 IBRO. Published by
Elsevier Ltd. All rights reserved.Key words: depression, anxiety, Crohn’s disease, oxidative stress, hippocampus, toll-like receptor pathway.INTRODUCTION
Inﬂammatory bowel disease (IBD), including Crohn’s
disease and ulcerative colitis, is a chronic disease
associated with psychiatric comorbidities such as
depression and anxiety (Chauhan et al., 2016; Mikocka-https://doi.org/10.1016/j.neuroscience.2017.10.023
0306-4522/ 2017 IBRO. Published by Elsevier Ltd. All rights reserved.
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124Walus et al., 2016). Psychiatric comorbidities in IBD
patients negatively aﬀect the quality of their lives and
the severity of disease in suﬀerings (van den Brink
et al., 2016; Yanartas et al., 2016). Evidence has shown
that the incidence of mood disorders is higher in patients
with IBD in comparison with other chronic diseases (Taft
and Keefer, 2016). Recent preclinical investigations have
revealed that induction of experimental colitis in rodents is
able to provoke psychopathologies such as depressive-
and anxiety-like behaviors in animals (Bercik et al.,
2010). In this regard, it has been shown that dextran
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panied by behavioral comorbidities (Reichmann et al.,
2015; Nyuyki-Dufe et al., 2016). Also, interleukin-10
knockout (IL-10/) mouse (an animal model for study-
ing IBD) shows anxiety-like behaviors and memory
impairments (Ku¨hn et al., 1993; Ohland et al., 2013). Con-
sidering direct association between IBD and psychologi-
cal disorders, only few studies have investigated the
underlying mechanisms involved in the comorbidity of
IBD and psychiatric disorders.
Emerging line of research suggests that oxidative and
nitrosative stress (O&NS) and immune-inﬂammatory
responses play important roles in the pathophysiology of
depression (Maes, 2008; Maes et al., 2009, 2011b;
Patki et al., 2013). Focusing on IBD, evidence has
recently suggested that oxidative challenge and pro-
inﬂammatory cytokines contribute to the pathophysiology
of IBD (Ghia et al., 2009; Maes et al., 2011b; Triantaﬁllidis
et al., 2013). Evidence also suggests that peripheral
inﬂammation in patients with chronic diseases is able to
initiate the development of mood disorders by triggering
inﬂammatory signaling in the brain (Tache´ and
Bernstein, 2009; Bonaz and Bernstein, 2013). Several
studies have suggested that gut damage is accompanied
by the activation of peripheral inﬂammatory responses,
which may be related to the development of mood disor-
ders in IBD patients (Fleshner, 2013; McCusker and
Kelley, 2013; Singhal et al., 2014). Toll-like receptors
(TLRs) are the main components of innate immunity,
which recognize the pathogen-associated molecular pat-
terns (PAMPs) such as lipopolysaccharide (LPS) and
damage-associated molecular patterns (DAMPs). Activa-
tion of TLRs leads to production of pro-inﬂammatory
cytokines such as IL-1b and IL-6, and nitric oxide (NO)
in the brain (Barksby et al., 2007; Klune et al., 2008;
Diacovich and Gorvel, 2010; Fleshner, 2013). The ele-
vated levels of pro-inﬂammatory cytokines and nitrosative
stress are capable of inhibiting the mitochondrial respira-
tory chain components and result in cellular energy deﬁ-
ciency (Mancuso et al., 2007; Maes et al., 2011a; Morris
and Maes, 2014). Considering the crucial role of mito-
chondria in massive production of reactive oxygen spe-
cies (ROS) under pathological conditions, a number of
studies suggest that abnormal mitochondrial function
and inﬂammatory responses may contribute to the patho-
genesis of depression (Rezin et al., 2009; Bakunina et al.,
2015; Crupi and Cuzzocrea, 2016).
In this study, we tested whether (1) experimental
model of Crohn’s disease is associated with the
development of behaviors related to anxiety and
depression, and (2) peripheral inﬂammation following
induction of colitis in mice activates the genes relevant
to innate immunity and oxidative stress in the
hippocampus.EXPERIMENTAL PROCEDURES
Animals
We used male NMRI mice purchased from the Pasteur
Institute, Tehran, Iran. All animals, weighing 25–30 g,
were housed in the groups (4 mice in each cage), andwere kept at the temperature of 21–23 C under a 12-h
consistent light/dark cycle and were given access to
food and water ad lib. All tests were performed between
10:00 and 14:00 h. All procedures were done in line with
the NIH Guide for the Care and Use of Laboratory
Animals (National Institutes of Health Publications No.
80-23, revised 1978) and the institutional guidelines for
animal care and use (Department of Pharmacology,
School of Medicine, Tehran University of Medical
Sciences). All experimental groups have been
demonstrated and designated in Table 1. Also, full
eﬀorts were made to minimize the use of animals and to
optimize their comfort.
Induction and characterization of colitisInduction of colitis. DNBS (Dinitrobenzene sulfonic
acid) (Sigma) was used to induce colitis. For this
purpose, 6 mg of DNBS dissolved in 100 lL of 50%
ethanol and slowly inject intra-rectally for each mouse.
Animals were deprived of food 24 h prior to colitis
induction, and were anesthetized using Isoﬂurane
inhalation (Sigma). DNBS was injected intra-rectally (i.r.)
using a ﬂexible catheter 5 cm in length. After that the
mice were held upside down in a 45 position for 2 min
in order to avoid leakage of the DNBS solution, and
were returned to their home cages. Animals were
assessed for the behavioral or molecular assessments 3
d after colitis induction when the peak of acute
inﬂammation occurs (Hollenbach et al., 2005). Control
groups received 100lL normal saline (i.r.) and were eval-
uated 3 d after injection.
Macroscopic assessment. Animals were euthanized
under deep anesthesia using isoﬂurane inhalation (3 d
after DNBS or saline injection), colon was dissected out
and cut open longitudinally and gently cleaned using
PBS. The assessment of inﬂammation was scored
based on ulceration, inﬂammation, and extent of
disease. The scoring system subordinates from
following scale from 0 to 9: 0 = normal aspect of the
mucosa, 1 = localized hyperemia without ulcerations, 2
= ulceration, 3 = ulceration with thickening of bowel
wall at one site, 4 = two or more sites of ulceration and
thickening of the bowel wall, 5 = major sites of damage
extending <2 cm along the length of the colon, and
6–9 = damage extending >2 cm (with the score
increasing by 1 for each centimeter of damaged tissue)
(El-Salhy et al., 2014).
Histopathological evaluation. In order to microscopic
assessments, the colon was cut into pieces and ﬁxed in
10% formalin. Formalin-ﬁxed colon segments were
paraﬃn-embedded and cut into 5-lm divisions. Nine
sections obtained from each colon and were
deparaﬃnized using xylene and stained with
hematoxylin and eosin (H&E) (Hasanvand et al., 2016).
Histological analysis was done under light microscopy
by a pathologist in consistent with the previously
described method (Obermeier et al., 1999). Each score
characterized the mean of nine sections of each colon.
Table 1. Experimental groups of the study: Injections and number of animals in each experimental group for behavioral or molecular/histopathological
tests were illustrated
Groups Injections Numb. Behavioral tests Molecular/Histological tests
IBD1 DNBS (6 mg, i.r.) 8 OFT & FST –
IBD2 DNBS (6 mg, i.r.) 8 HBT & splash test –
IBD3 DNBS (6 mg, i.r.) 8 EPM & TST –
IBD4 DNBS (6 mg, i.r.) 8 SPT –
IBD5 DNBS (6 mg, i.r.) 8 – Colon macroscopic and histopathologic evaluations
IBD6 DNBS (6 mg, i.r.) 8 – Colon MPO activity
IBD7 DNBS (6 mg, i.r.) 4 – Colon Gene expression
IBD8 DNBS (6 mg, i.r.) 4 – HIPP Mitochondrial factors
IBD9 DNBS (6 mg, i.r.) 4 – HIPP Nitrite assay
IBD10 DNBS (6 mg, i.r.) 4 – HIPP inﬂammatory genes
Control1 Saline (100 lL, i.r.) 8 OFT & FST –
Control1 Saline (100 lL, i.r.) 8 OFT & FST –
Control2 Saline (100 lL, i.r.) 8 HBT & splash test –
Control3 Saline (100 lL, i.r.) 8 EPM & TST –
Control4 Saline (100 lL, i.r.) 8 SPT –
Control5 Saline (100 lL, i.r.) 8 – Colon macroscopic and histopathologic evaluations
Control6 Saline (100 lL, i.r.) 8 – Colon MPO activity
Control7 Saline (100 lL, i.r.) 4 – Colon Gene expression
Control8 Saline (100 lL, i.r.) 4 – HIPP Mitochondrial factors
Control9 Saline (100 lL, i.r.) 4 – HIPP Nitrite assay
Control10 Saline (100 lL, i.r.) 4 – HIPP inﬂammatory genes
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normal morphology; 1, loss of goblet cells; 2, loss of gob-
let cells in large areas; 3, loss of crypts; 4, loss of crypts in
large areas. Inﬁltration (I): 0, no inﬁltrate; 1, inﬁltrate
around crypt basis; 2, inﬁltrate reaching to L. muscularis
mucosae; 3, extensive inﬁltration reaching the L. muscu-
laris mucosae and thickening of the mucosa with abun-
dant edema; 4, inﬁltration of the L. submucosa. The
total histological score represents the sum of the epithe-
lium and inﬁltration score (total score = E+ I).
Colonic myeloperoxidase (MPO) activity measure-
ment. MPO was assessed based on previously
described method (Abdolghaﬀari et al., 2010; Khanavi
et al., 2014). In brief, bowel samples were crushed on
ice and homogenized in 2 ml of 50 mmol/L phosphate buf-
fer, pH 7.4. Homogenizer probe was placed in a container
of ice. The homogenates were centrifuged for 30 min at
3500 g and 4 C. The upper liquid was removed and 1
ml of 50 mmol/L phosphate buﬀer, pH 6 containing 0.5%
Hexadecyltrimethylammonium bromide (Sigma) and 10
mmol EDTA (Sigma) added into sediment samples and
sonicated and then centrifuged for 20 min at 12,000 g
and 4 C. Subsequently, 15 ml from upper liquid phase
was added to an ELISA plate containing 240 ml of 50
mmol/L phosphate buﬀer, pH 6 containing 0.167 mg/ml
o-dianisidine (Sigma) and 0.0005% hydrogen peroxide
(Sigma, USA). The change in absorbance was measured
spectrophotometrically at 460 nm for 3 min. One unit of
MPO activity was described as the change in absorbance
per min at room temperature in the ﬁnal reaction and
expressed as unit per mg protein of colon tissue.
Quantitative reverse transcription–PCR (qRT-PCR).
RNA was extracted using Tripure isolation reagent
(Roche) according to the company’s instructions andquantiﬁed by a ND-100 spectrophotometer (Nanodrop
Technologies). Changes in mRNA expression of desired
genes were assessed by qRT–PCR after reverse
transcription of 1 lg RNA from each sample with
PrimeScript RT reagent kit (Takara) according to the
manufacturer’s order. The qRT–PCR was done on a
light cycler apparatus (Roche Diagnostics) using SYBR
Premix Ex Taq technology (Takara). Thermal cycling
environment involved an initial activation phase for 30 s
at 95 C followed by 45 cycles including a denaturation
step for 5 s at 95 C and a combined annealing/
extension step for 20 s at 60 C. In order to approve
that whether all primers yield a single PCR product,
melting curve analysis was applied. Hypoxanthine
phosphoribosyl transferase1 (Hprt1), was considered as
a normalizer and fold changes in expression of each
target mRNA relative to Hprt1 was calculated based on
2DDCt relative expression formula as described earlier
(Amini-Khoei et al., 2016; Amiri et al., 2017). The primer
sequences are listed in Table 2.Behavioral testsForced swimming test (FST). FST was used as an
approved behavioral test for evaluating the despair
behavior in which increase in the immobility time
presents the depressive-like behavior (Porsolt et al.,
1977; Cryan and Holmes, 2005). Mice were individually
placed in an open glass cylinder (diameter: 10 cm, height:
25 cm) containing 19 cm water (23 ± 1 C). Mice were
permitted to swim for 6 min and the immobility time was
documented during the last 4 min. Immobility behavior
was measured when the animal remained ﬂoating motion-
less in the water and made only those necessary activities
to keep its head above water.
Table 2. Primer sequences
Sequence (50 ? 30)
Gene Forward Reverse
Bdnf TTACCTGGATGCCGCAAACAT TGACCCACTCGCTAATACTGTC
Il-6 CTGCAAGAGACTTCCATCCAG AGTGGTATAGACAGGTCTGTTGG
Nlrp3 ATCAACAGGCGAGACCTCTG GTCCTCCTGGCATACCATAGA
Hmgb1 GCTGACAAGGCTCGTTATGAA CCTTTGATTTTGGGGCGGTA
Il-1b GAAATGCCACCTTTTGACAGTG TGGATGCTCTCATCAGGACAG
Tnf-a CTGAACTTCGGGGTGATCGG GGCTTGTCACTCGAATTTTGAGA
Hprt1 TGCTCGAGATGTGATGAAGG AAGCAGATGGCCACAGAACT
Myd88 ATCGCTGTTCTTGAACCCTCG CTCACGGTCTAACAAGGCCAG
Tlr-2 CTCTTCAGCAAACGCTGTTCT GGCGTCTCCCTCTATTGTATTG
Tlr-4 ATGGCATGGCTTACACCACC GAGGCCAATTTTGTCTCCACA
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suspended on the edge of a rod 50 cm above a table
top using adhesive scotch tape, located approximately
1 cm from the tip of the tail. Tail climbing was prohibited
by passing the mouse’s tail through a small plastic
cylinder prior to suspension. The duration of immobility
time was manually documented for 6 min. Mice were
considered immobile only when they hung down
passively and were completely immobile (Steru et al.,
1985; Cryan et al., 2005).
Splash test. Splash test used to evaluate the
motivational and self-care diﬃculties, in which grooming
behavior of mice, is considered as an indirect measure
of palatable solution drinking. A 10% sucrose solution
was spewed on the dorsal coat of animals while they
were in their home cages and mice were evaluated for
5 min. Duration of grooming activity behavior including
nose/face cleaning, head washing, and body grooming
was observed by a person blinded to the experiment
(David et al., 2009; Marrocco et al., 2014; Haj-Mirzaian
et al., 2015).
Sucrose preference test (SPT). SPT is considered as
an approved test to evaluate the hedonic state of rodents
(Wallace et al., 2009). In this regard, animals were intro-
duced to two bottles of tap water, which were placed in
the home cage of each mouse in the ﬁrst two days (1st
and 2nd days). Then, one of the bottles was substituted
by a bottle having 1% sucrose solution for the second
two days (3th and 4th days). On the test day (5th day), ani-
mals were deprived of food and water for 5 h and then
sucrose preference was assessed in one hour of liquid
consumption using two bottles of 1% sucrose solution
and tap water (DNBS/saline were injected in the 2nd
day). SPT was calculated using the following equation,
which evaluates the fraction of 1% sucrose solution con-
sumed to the total liquid consumed: Sucrose preference
= Sucrose consumed/(Sucrose consumed + tap water
consumed).
Open-field test (OFT). We used the OFT to elucidate
the eﬀects of colitis on motoric function and anxiety-like
behaviors (Kulesskaya and Voikar, 2014; Amiri et al.,
2016). The OFT apparatus consisted of a white opaque
Plexiglas box measuring (50 cm  50 cm  30 cm) whichwas dimly illuminated. Animals were placed individually
on the central zone of the apparatus (30 cm  30 cm)
and their behaviors were recorded by a camera for 5
min and were analyzed by Ethovision software version 8
(Noldus, Netherlands). Distance moved (horizontal activ-
ity), number of rearings (vertical activity) and time spent
in the central zone were evaluated.Hole-board test (HBT). Hole-board test presented as a
reliable trial to assess the anxiety-like behaviors in the
rodents (Takeda et al., 1998; Haj-Mirzaian et al., 2015).
The apparatus was made of a white Plexiglas square (5
0 cm  50 cm) with 16 equally sized holes (3 cm in diam-
eter) and was located 50 cm above the ﬂoor. Mice were
placed in the center of the board, and the number of
head-dips was calculated in a 5-min period by an
experimenter.Elevated plus maze (EPM). The EPM is an
appropriate test to assess the anxiety-like behavior in
mice (Ducottet and Belzung, 2005). The apparatus was
made of black opaque Plexiglas and consisted of two
open (30  5 cm) and closed (30  5  15 cm) arms,
which were attached by a platform area (5  5 cm). Test-
ing room was dimly illuminated and animals were individ-
ually placed in the center of the EPM facing to closed arm
and each behavioral session was videotaped for a 5-min
period and was analyzed by Ethovision software version
8 (Noldus, Netherlands). The time spent in the open arms
and number of entries into the open arms are described
as percentages.Nitrite assay
Mice in each group were fasted overnight and after
scariﬁcation, hippocampi were quickly dissected out and
soaked in the liquid nitrogen and kept at 80 C freezer
until the assays. To determine NO levels in the
hippocampus, we measured nitrite levels as the result of
the NO end product (Ding et al., 2010; Kordjazy et al.,
2015). Nitrite levels were measured by a colorimetric
assay based on the Griess reaction in each hippocampus
sample. Concentration of nitrite was determined by refer-
ence to a standard curve of sodium nitrite (Sigma) and
normalized to the weight of each sample.
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Animals were sacriﬁced and hippocampi were dissected
out, washed with PBS and stored at 80 C. Tissue
homogenization was done with cold mannitol solution (4
C) containing 0.225 M D-mannitol, 75 mM sucrose and
0.2 mM EDTA. The homogenate was centrifuged at
1000g for 10 min at 4 C. The supernatant was
centrifuged at 10,000g for 10 min as a source of
hippocampal mitochondria. The heavy mitochondrial
fraction was collected and re-suspended in the mannitol
solution and, re-centrifuged twice at 12,000g for 10
min. The resulting pellet (P2 fraction), including both
synaptic and non-synaptic mitochondria was re-
suspended in desired buﬀer based on oxidative stress
markers including ROS production, ATP, and
glutathione (GSH) (Wieckowski et al., 2009). To ensure
that the obtained suspension is pure mitochondria, MTT
test was conducted to conﬁrm the work according to pre-
vious works (Hosseini et al., 2014). Mitochondrial protein
concentration was determined by the Coomassie blue
protein-binding method using BSA as the standard
(Bradford, 1976). To keep the uniformity of experimental
condition, the mitochondrial samples (100 mg/ml mito-
chondrial protein) were used in all experiments.ROS formation. To measure mitochondrial ROS
formation on isolated hippocampi mitochondria,
mitochondrial suspension were incubated with 20,
70-dichloroﬂuorescein diacetate (DCFH-DA) (ﬁnal
concentration of 10 mM) in respiratory buﬀer including
KCl (130 mM), MgCl2 (5 mM), NaH2PO4 (20 mM), ADP
(1.7 mM), b-NADPH (0.1 mM), FeCl3 (0.1 mM), pH 7.4.
Mitochondrial ﬂuorescence and light scattering were
analyzed for at least 12000 counts per sample in the
ﬂowcytometry using the BD Biosciences FACS
CalibureTM ﬂowcytometer. Samples were gated on the
forward/side scatter to exclude cell debris and clumps.
A ﬂowcytometer with the Flomax software, equipped
with a 488-nm argon ion laser was used and
ﬂuorescence signals were obtained using a 530-nm
band pass ﬁlter (FL-1 channel) (Gao et al., 2009;
Hosseini et al., 2014; Amini-Khoei et al., 2017).ATP levels. Brieﬂy, 0.5 ml aliquot of isolated
mitochondria homogenate in TCA (6%) was mixed with
0.5 mL of KOH 0.05 M (on ice), then, 1 mL deionized
water was added; after 2 min, 650 lL of KH2PO4 (0.05
M) was added and vortexed. After ﬁltering, ATP level in
each sample was measured using luciferase enzyme as
described in our previous work (Eskandari et al., 2012).
Bioluminescence intensity was measured using Sirius
tube luminometer (Berthold Detection System, Germany).Glutathione (GSH) levels. Glutathione levels were
determined using 5, 50-dithiobis-(2-nitrobenzoic acid) or
DTNB as the indicator. Brieﬂy, 0.1 mL of supernatant
was added into 0.1 mol.L1 of phosphate buﬀer and
0.04% DTNB in a total volume of 3.0 mL (pH 7.4). The
developed color was measured at 412 nm using a
spectrophotometer (UV-1601 PC, Shimadzu, Japan).GSH content was expressed as mg mg1 protein
(Jayakumar et al., 2014).
Experimental design
Experimental design of the study consisting of injections
(colitis vs. control), number of animals in each
experimental group, and molecular/behavioral
assessments which were performed in each group is
summarized in Table 1.
Statistical analysis
The sample size was calculated by power calculations
using G power software (ver.3.1.7, Franz Faul,
Universitat Kiel, Germany). We set a error at 0.05 and
power (1-b) at 0.8 and the required total sample size
per group was calculated as 6–8 in behavioral tests and
3–4 in molecular studies. Comparison between the
groups was analyzed using t-test using the Graph-pad
prism software (version 6). P< 0.05 was considered
statistically signiﬁcant.
RESULTS
Assessment of colitis
In order to validate the DNBS-induced colitis, we have
assessed the possible eﬀect of DNBS on macroscopic
and histopathological features and scores, MPO activity
and pro-inﬂammatory cytokines expression levels.
Macroscopic evaluation
As shown in Fig. 1, the macroscopic scores were
signiﬁcantly higher in DNBS-treated mice when
compared with the saline-treated mice (t= 8.612, df=
12, P< 0.001).
Microscopic evaluation
In microscopic examination, epithelial damage and
inﬂammatory cell inﬁltration were detected in all DNBS-
treated samples. Massive neutrophilic inﬁltration
restricted to the mucosa as well as goblet cell and crypt
loss was evident, suggesting a pattern of colonic
damage. The histopathological scores were signiﬁcantly
higher in DNBS-treated mice when compared with the
saline-treated mice (t= 5.1, df= 14, P< 0.01,
Table 3, Fig. 2).
Colitis increased MPO activity in the colon tissue
MPO activity value in DNBS-treated group was
signiﬁcantly increased in comparison with the control
group (t= 16.63, df= 12, P< 0.001, Fig. 3).
Colitis increased expression of inﬂammatory genes
in the colon tissue
As shown in Fig. 4B, DNBS-induced colitis was
associated with signiﬁcant increase in the expression
levels of the colonic pro-inﬂammatory cytokines
including Il-1b (t= 5.454, df= 6, P< 0.01), Il-6
Fig. 1. Macroscopic scores of the colitis. Values are expressed as
mean ± SD (n= 8) and were analyzed using t-test. ***P< 0.001
compared to the control group.
Table 3. Histopathologic scores of the colon samples. Histopathologic
changes were scored semi-quantitatively. Values are expressed
as median and min–max (n= 8) and were analyzed using t-test.
**P< 0.01 compared to the control group
Group no Treatment Pathologic score
Median (min–max)
1 DNBS 4 (2–5)**
2 Control 1 (0–2)
Fig. 3. Myeloperoxidase (MPO) activity in the colitis. Data are
expressed as mean ± SEM (n= 8) and were analyzed using t-test.
***P< 0.001 compared to the control group.
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P< 0.05), Hmgb1 (t= 3.233, df= 6, P< 0.05), Tlr-2
(t= 2.681, df= 6, P< 0.05) and Tlr-4 (t= 5.112,
df= 6, P< 0.01) as compared with the control saline-
treated group.Colitis provoked behaviors relevant to depression
and anxiety
Analyses revealed that applying colitis using DNBS
induced depressive- and anxiety-like behaviors in
animals. We demonstrated the impact of colitis onFig. 2. Representative features of histopathologic evaluations provided from
sections (100). (A) The saline-treated group, the normal mucus layer
leukocyte inﬁltration; (B) The DNBS-treated group, mucosal layer with l
(arrow).depressive-like behaviors using FST, TST, splash test
and SPT. The possible eﬀect of colitis on locomotor
activity and anxiety-like behaviors were determined
using OFT, HBT, and EPM.
Colitis increased immobility time in the FST and TST
Results showed that the immobility time, main indicator of
despair behavior, increased in DNBS-treated animals
when compared with control groups in the FST
(t= 8.945, df= 14, P< 0.001, Fig. 5A) and TST
(t= 3.465, df= 14, P< 0.01, Fig. 5B).
Colitis decreased grooming activity time in the
splash test
As shown in Fig. 5C, colitis caused self-care disturbance
and signiﬁcantly reduced grooming activity time in the
splash test in comparison with the control group (t=
7.443, df= 14, P< 0.001).
Colitis decreased sucrose intake in the SPT. Our
ﬁnding determined that colitis was accompanied with an
anhedonic condition. SPT results showed that induction
of colitis with DNBS signiﬁcantly reduced sucrose
consumption in comparison with control mice (t= 5.99,H & E-stained colon
and crypts without
eukocyte inﬁltrationdf= 14, P< 0.001, Fig. 5D).
Colitis decreased time spent in
central zone without change in
locomotor activity in the OFT
In the OFT, there is no signiﬁcant
diﬀerence in the total distance moved
(horizontal activity) (t= 0.3119, df=
14, P> 0.05, Fig. 6A) and number of
rearings (vertical activity) (t= 0.6544,
df= 14, P> 0.05, Fig. 6B) between
colitis and control groups. As shown
in Fig. 6C, DNBS-treated animals
spent less time in the central zone of
the OF apparatus in comparison with
the control animals (t= 3.035, df=
10, P< 0.05).
Fig. 4. The expression of Il-1b, Tnf-a, Tlr4, Tlr2, Il-6 and Hmgb1 in the hippocampus (A) and the colon (B) tissues were determined by qRT–PCR.
Data are shown as mean ± SEM (n= 4) and were analyzed using t-test. *P< 0.05, **P< 0.01 and ***P< 0.001 compared to the control
counterparts. Il-1b: interleukin-1 beta, Tnf-a: tumor necrosis factor alpha, Tlr4: toll-like receptor 4, Tlr2: toll-like receptor 2, Il-6: interleukin 6 and
Hmgb1: high mobility group box 1protein.
Fig. 5. Eﬀects of colitis on depressive-like behaviors including immobility time in the FST (A),
immobility time in the FST (B), grooming activity time in the splash test (C) and percent of sucrose
consumption in SPT (D). Values are expressed as the mean ± S.E.M. (n= 8) and were
analyzed using t-test. **P< 0.01 and ***P< 0.001 compared to the control group. FST: forced
swimming test, SPT: sucrose preference test.
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As shown in Fig. 6D, colitis caused a signiﬁcant decrease
in number of head-dips in IBD group when compared with
control animals (t= 3.402, df= 14, P< 0.01).Open arm time and entries decreased in colitic mice
in the EPM
In the EPM, percentage of spent time in the open arms
and percentage of open arms entries were evaluated asvariables relevant to anxiety-like
behaviors. In comparison with the
control animals, DNBS administration
remarkably decreased percentage of
spent time in the open arms
(t= 2.331, df= 14, P< 0.05,
Fig. 6E) as well as percentage of
open arms entries (t= 4.122, df= 14,
P< 0.01, Fig. 6F) in IBD mice.Colitis increased expression of
genes related to inﬂammation in the
hippocampus
Fig. 4A shows the eﬀects of IBD on
expression of genes related to
inﬂammatory markers. t-test analysis
demonstrated the over-expression of
Tlr-2 (t= 5.421, df= 6, P< 0.01),
Tlr-4 (t= 7.131, df= 6, P< 0.001),
Myd88 (t= 4.330, df= 6, P< 0.01)
and Hmgb1 (t= 3.745, df= 6,
P< 0.01) in hippocampus of IBD
groups in comparison with the control
animals. Also, signiﬁcant rise in
expression of Tnf-a (t= 4.272, df=
6, P< 0.01) and Il-6 (t = 2.771, df
= 6, P< 0.05) was observed in the
hippocampus of the colitic mice in
comparison with the control mice.
Our ﬁndings showed that there is nosigniﬁcant diﬀerence in the expression of Il-1b (t= 5.1,
df= 14, P> 0.05) and nlrp3 (t= 1.324, df= 6,
P> 0.05) in the hippocampus of colitic mice when
compared with the control mice.
In addition, as presented in Fig. 7, colitis signiﬁcantly
decreased Bdnf expression in hippocampus in
comparison with saline-treated mice (t= 2.594, df= 6,
P< 0.05).
Fig. 6. Eﬀect of colitis on behaviors related to anxiety and locomotor activity. Total distance
moved in the OFT (A), number of rearings in the OFT (B), time spent in the central zone in the
OFT (C), number of head-dips in the HBT (D),% open arm time in the EPM (E), and % open arm
entries in EPM (F). Values are expressed as the mean ± S.E.M. (n= 8) and were analyzed
using t-test. *P< 0.05 and **P< 0.01 compared to the control group. OFT: open-ﬁeld test, EPM:
elevated plus maze, HBT: hole-board test.
Fig. 7. The expression of Bdnf in the hippocampus was determined
by qRT-PCR. Data are shown as mean ± SEM (n= 4) and were
analyzed using t-test. *P< 0.05 compared to the control counter-
parts. Bdnf: brain-derived neurotrophic factor.
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dysfunction and NO
overproduction in the
hippocampus
The eﬀects of colitis on hippocampal
mitochondria parameters including
GSH and ATP levels as well as ROS
production were presented in
Table 4. Results obtained from t-test
analysis revealed that there was a
signiﬁcant decrease in GSH levels in
the colitic group when compared with
the control group (t= 6.979, df= 8,
P< 0.001). Also, a signiﬁcant
decrease in ATP levels was observed
in the colitic mice as compared with
the controls (t= 18.97, df= 8, P<
0.01).
Furthermore, assessment of ROS
formation was performed in 2 time
intervals (5 min and 45 min) in the
IBD and the control groups. Results
obtained from t-test demonstrated
that colitis signiﬁcantly increased
levels of ROS in the hippocampus in
intervals 5 min (t= 6.397, df= 11,
P< 0.0) and 45 min (t= 4.545, df
= 14, P< 0.001) in comparison with
control group (Table 5).
We have also evaluated the impact
of colonic inﬂammation on hippocampal
nitrite levels. Analysis revealed that
colitic animals have a higher level of
hippocampal nitrite content in
comparison with the controls (t=8.497,
df= 8, P< 0.001, Table 4).DISCUSSION
Results of the current study showed
that depressive- and anxiety-like
behaviors in an animal model of CDare associated with increased transcription of the genes
relevant to innate immunity in the hippocampus. In
addition, altered expression of these genes was
accompanied by an overproduction of ROS and NO in
hippocampus of animals. We found that colonic
inﬂammatory responses were associated with the
inﬁltration of inﬂammatory cells and the increased
expression of the genes involved in TLRs pathway in
intestinal tissue. These alterations were accompanied
by increased transcriptional levels of the genes relevant
to innate-immunity in the hippocampus of colitic mice.
Further, activation of innate immunity was associated
with behavioral abnormalities and oxidative stress in the
hippocampus. These results suggest that association
between peripheral and central immune-inﬂammatory
responses play a critical role in the co-occurrence of
depression and anxiety in CD.
In the current work, using an experimental model of
colitis, we observed a signiﬁcant inﬂammation in the
Table 4. Eﬀect of colitis on GSH, ATP, and nitrite levels in the
hippocampus: Values are expressed as Mean ± S.D. (n= 4) and
were analyzed using t-test. **P< 0.01 and ***P< 0.001 compared with
control group. GSH: glutathione, ATP: adenosine triphosphate
GSH ATP Nitrite
(mg/mg
protein)
(nmol/mg
tissue)
(nmol/mg
protein)
Control 14.7 ± 2.3 3.2 ± 0.2 79.48 ± 2.8
Colitis 5.36 ± 1.7*** 1.28 ± 0.13** 147.4 ± 3.2***
Table 5. % increase of ROS formation in hippocampus after induction
of colitis. Values are expressed as Mean ± S.D. (n= 4) and were
analyzed using t-test. **P< 0.01 and ***P< 0.001 compared with
control group. ROS: reactive oxygen species
Groups DCF ﬂuorescence intensity (%)
5 min 45 min
Control 3 ± 2 9 ± 1
Colitis 12 ± 1** 157 ± 14***
132 A. Haj-Mirzaian et al. / Neuroscience 366 (2017) 124–137colonic tissue that was conﬁrmed by pathological and
molecular evaluations. Inﬁltration of inﬂammatory cells
such as PMN cells and macrophages into colonic tissue
was accompanied by an increase in the MPO level and
upregulation of the Tlr-2 and 4 and Hmgb1 as well as
pro-inﬂammatory cytokines including Tnf-a, Il-1b, and Il-
6. Ample evidence has demonstrated the signiﬁcant
contribution of pro-inﬂammatory cytokines in the
pathogenesis of IBD (Strober and Fuss, 2011; Senhaji
et al., 2016). Inﬂamed intestinal barrier contains antigen-
presenting cells such as macrophages which produce
several inﬂammatory factors (Papadakis and Targan,
2000). In this regard, IL-1b is known to increase the para-
cellular permeability of the intestinal mucosa/epithelium,
and has been suggested as a determinant factor for the
initiation of disease (Al-Sadi et al., 2008; Neurath,
2014). Also, TNF-a and IL-6 are known to mediate the
majority of systemic inﬂammatory responses in IBD,
which account for the disease progression, perpetuation
and comorbid diﬃculties (Leppkes et al., 2014; Neurath,
2014; Waldner and Neurath, 2014). These results are in
line with previous investigations, which have reported that
experimental models of colitis have severe colonic dam-
age and pervasive inﬂammatory responses in the intesti-
nal tissue (Martin-Subero et al., 2015; Heydarpour et al.,
2016).
We used validated and qualiﬁed behavioral tests for
the evaluation of anxiety- and depressive-like behaviors
in rodents. We found that the colitic mice exhibited
behaviors relevant to anxiety and depression 3 d
following DNBS-induced injury. Increased immobility
time in both FST and TST reﬂects the inability of
rodents to cope with an acute unescapable challenge
reﬂecting the depressive-like behaviors similar to
behavioral despair observed in depressed people
(Cryan and Holmes, 2005). Results of this work revealed
that the colitic mice not only had a signiﬁcant increase in
the immobility time, but also had a decline in sucrose pref-
erence and consumption as well as self-care disturbancein SPT and splash test. A decrease in consumption of
sucrose 1% in the SPT and low response (decrease in
grooming activity time) to sucrose 10% in splash test have
been reported as behaviors associated with anhedonia
and motivational diﬃculties in rodents (Der-Avakian and
Markou, 2012; Marrocco et al., 2014; Petit et al., 2014;
Amiri et al., 2015b). Also, the depressive behaviors of col-
itic animals in our experiments were not related to the
changes of locomotion. Although the FST and TST are
trusted behavioral tests, false negative results might be
obtained with sedation and sickness conditions. However,
the results we observed in this study do not seem to be
associated with locomotion changes, since DNBS-
induced colitis did not change the locomotion in the
OFT. Further, we have shown that colitis provoked
anxiety-like behaviors in OFT (decrease in spent time in
the central zone), EPM (decrease in both frequency and
spent time in open arms), and HBT (decrease in the num-
ber of head-dips). This behavioral proﬁle indicates that the
induction of colitis in mice is associated with the co-
occurrence of anxiety- and depressive-like behaviors.
Clinical and preclinical investigations have recently
demonstrated that not only intestinal damage in IBD
induces behaviors relevant to aﬀective disorders, but also
inﬂammatory factors play a part in mediation of these neg-
ative behavioral changes (Hassan et al., 2014; Pellissier
et al., 2014; Heydarpour et al., 2016). Prevalence of
depression and/or anxiety is more common in patients
with IBD in comparison with the general population, sug-
gesting that patients with IBD require psychiatric care
(Magni et al., 1991; Addolorato et al., 1997; Kurina
et al., 2001).
There is a consensus agreement that oxidative
challenge and inﬂammatory pathways are bidirectional
bridges that link diversity of systemic diseases to
negative aﬀective disorders (Slavich and Irwin, 2014;
Martin-Subero et al., 2015). Emerging lines of research
have highlighted the role of brain–gut axis in the comor-
bidity of psychiatric disorders and bowel diseases
(Kennedy et al., 2014; Severance et al., 2014; Mayer
et al., 2014a, 2014b). It has been well documented that
immune-inﬂammatory cascades play a pivotal role in the
development of negative aﬀective disorders such as anx-
iety and depression (Irwin and Miller, 2007; Maes, 2011).
Recent investigations have demonstrated that activation
of TLRs in cortico-limbic regions contribute to pathobiol-
ogy of several brain disorders including anxiety and
depression (Dantzer et al., 2008; Wohleb, 2013). In the
current study, depressive- and anxiety-like behaviors in
colitic mice were accompanied by an increase in the
expression of genes relevant to innate immunity such as
TLRs and NLRP3 pathways. Overexpression of the Tlr2
and Tlr4 in the hippocampus was associated with upreg-
ulation of Myd88 as the main regulatory protein of the
TLRs pathway. Stimulation of TLR-4 and TLR-2 activate
several signaling pathways in the CNS which lead to the
initiation of inﬂammatory responses. Recently published
results by our colleagues showed that TNBS-induced col-
itis induces behavioral despair in animals and these
behavioral changes are associated with a signiﬁcant
increase in hippocampal TNF-a and iNOS protein levels
A. Haj-Mirzaian et al. / Neuroscience 366 (2017) 124–137 133(Heydarpour et al., 2016). Moreover, inhibition of iNOS by
aminoguanidine reversed the despair behavior of animals
in the FST and decreased both iNOS and TNF-a level in
the hippocampus (Bakunina et al., 2015; Heydarpour
et al., 2016). In this work, we observed that DNBS-
induced colitis not only increased nitrite contents in the
hippocampus, but also induced mitochondrial abnormali-
ties and oxidative challenge. We found a considerable
decrease in hippocampal ATP levels, suggesting that
mitochondria were not able to produce enough energy
supply following DNBS challenge. Using ﬂowcytometry,
a valid and quantitative tool for the measurement of mito-
chondrial ROS, we observed a time-dependent increase
in mitochondrial derived ROS suggesting the abnormal
function of mitochondria in the hippocampus. Also, a sig-
niﬁcant decrease in the GSH levels, as the main antioxi-
dant in the brain, indicates that overproduction of ROS
and NO causes oxidative challenge in the hippocampus.
In this regard, previous investigations have highlighted
the role of oxidative challenge and nitrergic system in
modulation of anxiety- and depressive-like behaviors
(Amiri et al., 2015a; Haj-Mirzaian et al., 2016). Mitochon-
dria are intracellular organelles which have pivotal role in
ATP production in the cells (Calabrese et al., 2001). Mito-
chondrial dysfunction as defect in biochemical cascade or
damage to the mitochondrial respiratory chain has been
recommended as a main factor in the pathogenesis of
neuropsychiatric disorders such as anxiety and depres-
sion (Rezin et al., 2009; Hovatta et al., 2010; Tobe,
2013). Suggesting, brain metabolism impairment and
decrease in mitochondrial ATP can be considered as a
mechanism underlying psychiatry disorders (Fattal et al.,
2006; Burroughs and French, 2007; Rossignol and Frye,
2015). In this regard, it is demonstrated that potent anxi-
olytic and antidepressant agents may improve and protect
mitochondrial eﬃciency and function indicating mitochon-
drial function may be linked to the pathophysiology and
treatment of behavioral/mood disorders (Einat et al.,
2005; Burroughs and French, 2007).
Clinical and preclinical studies have suggested that
peripheral inﬂammatory responses in IBD trigger the
initiation of immune-inﬂammatory pathways in the brain
through diﬀerent pathways (Maes et al., 2011b; Martin-
Subero et al., 2015). Despite the extensive research in
the bidirectional eﬀects of brain–gut axis, it is not clear
how inﬂammatory factors in the bowel can inﬂuence
behavioral proﬁle suﬀerings. Focusing on animal studies,
recent studies have demonstrated that TNBS-induced
colitis is able to enhance neuronal excitability and inﬂam-
matory responses in the hippocampus through increasing
the activity of glutamatergic system and TNF-a (Neurath
et al., 2000; Boisse´ et al., 2003; Riazi et al., 2008).
Although several mechanisms have been proposed to
mediate comorbidity of behavioral diﬃculties in IBD, most
of researchers suggest that cytokines are key mediators
of such responses (Mackner et al., 2011). Our results
revealed that upregulation of Tlr2 and Tlr4 genes in the
hippocampus was associated with an increase in the
expression of inﬂammatory genes (MyD88, IL-6, and
TNF-a) as well as oxidative and nitrosative stress. How-
ever, the main question is that how TLR-2 and TLR-4were activated in the hippocampus of mice which experi-
enced DNBS-induced colitis. To answer this question, we
focused on the expression of the Hmgb1 gene.
It has been well documented that HMGB1 modulates
the systemic inﬂammatory responses in vast majority of
disorders and in case of IBD, this factor has been
suggested as the clinical marker for IBD diagnosis in
the stool of patients (Alex et al., 2007; El Gazzar,
2007; Chassaing et al., 2012). In addition, HMGB1 is
known as a well-known DAMP that accounts for activa-
tion of both TLR-2 and TLR-4 in variety of inﬂammatory
diseases (Yu et al., 2006; Mudaliar et al., 2013). In line
with previous reports, we observed an upregulation in
the HMGB1 gene not only in the colon tissue, but also
in the hippocampus of colitic mice indicating that this
molecule at least in part, mediates the primary inﬂamma-
tory responses in the CNS which results in appearance
of behavioral comorbidities. Hippocampus has high den-
sity of microglial cells. It has been suggested that activa-
tion of hippocampal microglial implicated in the
pathophysiology of psychiatric and stress-related disor-
ders (Rohan Walker et al., 2013; Brites and
Fernandes, 2015). In this context, it has been shown
that activation of HMGB1 is associated with depression
while blockage of HMGB1 attenuated the depressive-
like behaviors (Weber et al., 2015; Wu et al., 2015). Fur-
ther, we also found that the expression of brain-derived
neurotrophic factor (BDNF) was signiﬁcantly lower in col-
itic animals. This neurotrophic factor has a pivotal role in
neuronal survival, regulation of neuronal diﬀerentiation,
migration and activity-dependent synaptic plasticity
(Duman et al., 2000; Vutskits et al., 2001). It has been
demonstrated that decreased BDNF expression in the
hippocampus is associated with pathophysiology of
depression-like behaviors. The fundamental role of
BDNF in pathophysiology of neuropsychiatric diseases
is approved by this fact that its level can be
improved by neuropsychiatric medications, such as
antidepressants, mood stabilisers and antipsychotics
(Harrisberger et al., 2015).
It should be noted that we report DNBS-induced
alterations at transcriptional level, and our results would
be improved if we measure these alterations at protein
levels. In addition, we could improve results of this study
by applying a pharmacological treatment to animals (such
as an anti-inﬂammatory compound or antioxidant) to show
the involvement of oxidative stress and inﬂammatory
responses in behavioral abnormalities following colitis.
However, our results showed that colitic mice exhibit a
wide range of behaviors relevant to anxiety and
depression. Our results also revealed that altered
hippocampal energy and redox status may play a role in
aggravating the inﬂammatory signaling following
induction of colitis in mice. Although we showed the
increased transcription of Hmgb1 in both central and
peripheral tissues, we could not show that HMGB1
triggers the inﬂammatory responses in the hippocampal
formation. We believe that further research is needed to
investigate the role of toll-like receptor pathway and
mitochondrial function in the co-occurrence of anxiety
and depression in IBD.
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have been considered as useful for treating both IBD
and mood disorders. Plant compounds extracted from
Glycyrrhiza uralensis (Chinese licorice), Magnolia
oﬃcinalis, Zingiber oﬃcinale (ginger), Salvia miltiorrhiza
and curcumin exert anti-inﬂammatory eﬀects through
interacting with TLR-4 pathway (Lucas and Maes,
2013). For instance, epigallocatechin-3-gallate (EGCG)
is a polyphenol compound found in green tea, and is able
to inhibit the MyD88 signaling (Youn et al., 2006). Further,
6-shoagol, as an active compound of ginger, is able to
block the activity of inhibitor-jB kinase (Park et al.,
2009). Many studies have shown that most of these herbs
are useful for the treatment of IBD and depression (Xu
et al., 2005; Zhao et al., 2008; Sun et al., 2009; Ung
et al., 2010). Focusing on mitochondrial function and
oxidative & nitrosative stress, studies have shown that
reducing mitochondrion-induced oxidative stress have
modulating eﬀects on TLR pathway and is useful to allevi-
ate symptoms in both depression and IBD (Tirosh et al.,
2007; Lucas and Maes, 2013; Heydarpour et al., 2016;
Sonei et al., 2017). For example, N-acetylcysteine
(NAC) is a strong radical scavenger that showed thera-
peutic eﬀects in both depression and IBD (Cetinkaya
et al., 2005; Magalha˜es et al., 2011). In addition, inhala-
tion or consumption of hydrogen (hydrogen-enriched
water) is able to decrease the activity of TLR4 pathway
by inhibiting NF-kB activity (Ito et al., 2011; Ohno et al.,
2012). It has been shown that consumption of
hydrogen-enriched water is able to alleviate the mitochon-
drial dysfunction and inﬂammatory responses (Li et al.,
2012; Xie et al., 2012). Interestingly, studies have shown
the eﬃcacy of hydrogen consumption in the treatment of
both colitis and psychiatric disorders (Carbonero et al.,
2012; Ghanizadeh and Berk, 2013).CONCLUSION
Using an experimental animal model of Crohn’s disease,
our results showed that behavioral abnormalities in early
stages of disease are associated with immune-
inﬂammatory responses (at transcript level) in both
colon and hippocampus. We demonstrated that DNBS-
induced colitis is able to provoke anxiety- and
depressive-like behaviors in animals. These behavioral
changes were accompanied by altered energy
metabolism and oxidative and nitrosative stress in the
hippocampus as well as increased expression of genes
in TLR-pathway. In addition, we suggest that HMGB1,
as an endogenous ligand for Tlr-2 and Tlr-4, may play a
role in the activation of inﬂammatory responses in the
brain and occurrence of abnormal behaviors in animals.Acknowledgments—The authors would be thankful to Dr. Tah-
mineh Mokhtari for her helpful collaborations on this study.
This work was supported by a grant (96002757) from Iran
National Science Foundation (INSF).REFERENCES
Abdolghaﬀari AH, Baghaei A, Moayer F, Esmaily H, Baeeri M,
Monsef-Esfahani HR, Hajiaghaee R, Abdollahi M (2010) On the
beneﬁt of Teucrium in murine colitis through improvement of toxic
inﬂammatory mediators. Hum Exp Toxicol 29:287–295.
Addolorato G, Capristo E, Stefanini G, Gasbarrini G (1997)
Inﬂammatory bowel disease: a study of the association between
anxiety and depression, physical morbidity, and nutritional status.
Scand J Gastroenterol 32:1013–1021.
Alex P, Frank M, Dozmorov I, Levy V, Sutton C, Turner S, Miner P, Li
X, Centola M (2007) Novel targets identiﬁed in gene expression
proﬁles from patients with inﬂammatory bowel disease: O-0013.
Inﬂamm Bowel Dis 13:646.
Al-Sadi R, Ye D, Dokladny K, Ma TY (2008) Mechanism of IL-1b-
induced increase in intestinal epithelial tight junction permeability.
J Immunol 180:5653–5661.
Amini-Khoei H, Momeny M, Abdollahi A, Dehpour AR, Amiri S, Haj-
Mirzaian A, Tavangar SM, Ghaﬀari SH, Rahimian R, Mehr SE
(2016) Tropisetron suppresses colitis-associated cancer in a
mouse model in the remission stage. Int Immunopharmacol
36:9–16.
Amini-Khoei H, Mohammadi-Asl A, Amiri S, Hosseini M-J, Momeny
M, Hassanipour M, Rastegar M, Haj-Mirzaian A, Haj-Mirzaian A,
Sanjarimoghaddam H (2017) Oxytocin mitigated the depressive-
like behaviors of maternal separation stress through modulating
mitochondrial function and neuroinﬂammation. Prog
Neuropsychopharmacol Biol Psychiatry 76:169–178.
Amiri S, Amini-Khoei H, Haj-Mirzaian A, Rahimi-Balaei M,
Naserzadeh P, Dehpour A, Mehr SE, Hosseini M-J (2015a)
Tropisetron attenuated the anxiogenic eﬀects of social isolation by
modulating nitrergic system and mitochondrial function. Biochim
Biophys Acta (BBA)-Gen Subj 1850:2464–2475.
Amiri S, Haj-Mirzaian A, Rahimi-Balaei M, Razmi A, Kordjazy N,
Shirzadian A, Mehr SE, Sianati H, Dehpour AR (2015b) Co-
occurrence of anxiety and depressive-like behaviors following
adolescent social isolation in male mice; possible role of nitrergic
system. Physiol Behav 145:38–44.
Amiri S, Amini-Khoei H, Mohammadi-Asl A, Alijanpour S, Haj-
Mirzaian A, Rahimi-Balaei M, Razmi A, Olson CO, Rastegar M,
Mehdizadeh M (2016) Involvement of D1 and D2 dopamine
receptors in the antidepressant-like eﬀects of selegiline in
maternal separation model of mouse. Physiol Behav
163:107–114.
Amiri S, Haj-Mirzaiain A, Momeny M, Amini-Khoei H, Rahimi-Balaei
M, Poursaman S, Rastegar M, Nikoui V, Mokhtari T, Ghazi-
Khansari M (2017) Streptozotocin induced oxidative stress, innate
immune system responses and behavioral abnormalities in male
mice. Neuroscience 340:373–383.
Bakunina N, Pariante CM, Zunszain PA (2015) Immune mechanisms
linked to depression via oxidative stress and neuroprogression.
Immunology 144:365–373.
Barksby H, Lea S, Preshaw P, Taylor J (2007) The expanding family
of interleukin-1 cytokines and their role in destructive
inﬂammatory disorders. Clin Exp Immunol 149:217–225.
Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X,
Malinowski P, Jackson W, Blennerhassett P, Neufeld KA (2010)
Chronic gastrointestinal inﬂammation induces anxiety-like
behavior and alters central nervous system biochemistry in
mice. Gastroenterology 139(2102–2112):e2101.
Boisse´ L, Sickle MDV, Sharkey KA, Pittman QJ (2003) Compromised
neuroimmune status in rats with experimental colitis. J Physiol
548:929–939.
Bonaz BL, Bernstein CN (2013) Brain-gut interactions in inﬂammatory
bowel disease. Gastroenterology 144:36–49.
Bradford MM (1976) A rapid and sensitive method for the quantitation
of microgram quantities of protein utilizing the principle of protein-
dye binding. Anal Biochem 72:248–254.
Brites D, Fernandes A (2015) Neuroinﬂammation and depression:
microglia activation, extracellular microvesicles and microRNA
dysregulation. Front Cell Neurosci 9.
A. Haj-Mirzaian et al. / Neuroscience 366 (2017) 124–137 135Burroughs S, French D (2007) Depression and anxiety: role of
mitochondria. Curr Anaesth Crit Care 18:34–41.
Calabrese V, Scapagnini G, Stella AG, Bates T, Clark J (2001)
Mitochondrial involvement in brain function and dysfunction:
relevance to aging, neurodegenerative disorders and longevity.
Neurochem Res 26:739–764.
Carbonero F, Beneﬁel AC, Gaskins HR (2012) Contributions of the
microbial hydrogen economy to colonic homeostasis. Nat Rev
Gastroenterol Hepatol 9:504–518.
Cetinkaya A, Bulbuloglu E, Kurutas EB, Ciralik H, Kantarceken B,
Buyukbese MA (2005) Beneﬁcial eﬀects of N-acetylcysteine on
acetic acid-induced colitis in rats. Tohoku J Exp Med
206:131–139.
Chassaing B, Srinivasan G, Delgado MA, Young AN, Gewirtz AT,
Vijay-Kumar M (2012) Fecal lipocalin 2, a sensitive and broadly
dynamic non-invasive biomarker for intestinal inﬂammation. PLoS
ONE 7:e44328.
Chauhan U, Farbod Y, Marshall J, Halder S, Armstrong D, Tse F,
Popov J, Kaasalainen S, Moayyedi P (2016) P-079 YI The
Association Between Anxiety and Depression and Health Related
Quality of Life in Patients with Inﬂammatory Bowel Disease (IBD).
Inﬂamm Bowel Dis 22:S34.
Crupi R, Cuzzocrea S (2016) Neuroinﬂammation and immunity: a
new pharmacological target in depression. CNS Neurol Disord-
Drug Targets (Formerly Curr Drug Targets-CNS Neurol Dis)
15:464–476.
Cryan JF, Holmes A (2005) The ascent of mouse: advances in
modelling human depression and anxiety. Nat Rev Drug
Discovery 4:775–790.
Cryan JF, Mombereau C, Vassout A (2005) The tail suspension test
as a model for assessing antidepressant activity: review of
pharmacological and genetic studies in mice. Neurosci
Biobehav Rev 29:571–625.
Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW
(2008) From inﬂammation to sickness and depression: when the
immune system subjugates the brain. Nat Rev Neurosci 9:
46–56.
David DJ, Samuels BA, Rainer Q, Wang J-W, Marsteller D, Mendez I,
Drew M, Craig DA, Guiard BP, Guilloux J-P (2009) Neurogenesis-
dependent and-independent eﬀects of ﬂuoxetine in an animal
model of anxiety/depression. Neuron 62:479–493.
Der-Avakian A, Markou A (2012) The neurobiology of anhedonia and
other reward-related deﬁcits. Trends Neurosci 35:68–77.
Diacovich L, Gorvel J-P (2010) Bacterial manipulation of
innate immunity to promote infection. Nat Rev Microbiol 8:
117–128.
Ding J, Li QY, Wang X, Sun CH, Lu CZ, Xiao BG (2010) Fasudil
protects hippocampal neurons against hypoxia-reoxygenation
injury by suppressing microglial inﬂammatory responses in mice.
J Neurochem 114:1619–1629.
Ducottet C, Belzung C (2005) Correlations between behaviours in the
elevated plus-maze and sensitivity to unpredictable subchronic
mild stress: evidence from inbred strains of mice. Behav Brain
Res 156:153–162.
Duman RS, Malberg J, Nakagawa S, D’Sa C (2000) Neuronal
plasticity and survival in mood disorders. Biol Psychiatry
48:732–739.
Einat H, Yuan P, Manji HK (2005) Increased anxiety-like behaviors
and mitochondrial dysfunction in mice with targeted mutation of
the Bcl-2 gene: further support for the involvement of
mitochondrial function in anxiety disorders. Behav Brain Res
165:172–180.
El Gazzar M (2007) HMGB1 modulates inﬂammatory responses in
LPS-activated macrophages. Inﬂamm Res 56:162–167.
El-Salhy M, Umezawa K, Gilja OH, Hatlebakk JG, Gundersen D,
Hausken T (2014) Amelioration of severe TNBS induced colitis by
novel AP-1 and NF-jB inhibitors in rats. Sci World J.
Eskandari MR, Fard JK, Hosseini M-J, Pourahmad J (2012)
Glutathione mediated reductive activation and mitochondrial
dysfunction play key roles in lithium induced oxidative stress
and cytotoxicity in liver. Biometals 25:863–873.Fattal O, Budur K, Vaughan AJ, Franco K (2006) Review of the
literature on major mental disorders in adult patients with
mitochondrial diseases. Psychosomatics 47:1–7.
Fleshner M (2013) Stress-evoked sterile inﬂammation, danger
associated molecular patterns (DAMPs), microbial associated
molecular patterns (MAMPs) and the inﬂammasome. Brain Behav
Immun 27:1–7.
Gao P, Qian DH, Li W, Huang L (2009) NPRA-mediated suppression
of AngII-induced ROS production contribute to the antiproliferative
eﬀects of B-type natriuretic peptide in VSMC. Mol Cell Biochem
324:165–172.
Ghanizadeh A, Berk M (2013) Molecular hydrogen: an overview of its
neurobiological eﬀects and therapeutic potential for bipolar
disorder and schizophrenia. Med Gas Res 3:11.
Ghia JE, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM
(2009) Reactivation of inﬂammatory bowel disease in a mouse
model of depression. Gastroenterology 136(2280–2288):e2284.
Haj-Mirzaian A, Amiri S, Kordjazy N, Rahimi-Balaei M, Haj-Mirzaian
A, Marzban H, Aminzadeh A, Dehpour AR, Mehr SE (2015)
Blockade of NMDA receptors reverses the depressant, but not
anxiogenic eﬀect of adolescence social isolation in mice. Eur J
Pharmacol 750:160–166.
Haj-Mirzaian A, Amiri S, Amini-Khoei H, Rahimi-Balaei M, Kordjazy
N, Olson CO, Rastegar M, Naserzadeh P, Marzban H, Dehpour
AR (2016) Attenuation of oxidative and nitrosative stress in
cortical area associates with antidepressant-like eﬀects of
tropisetron in male mice following social isolation stress. Brain
Res Bull 124:150–163.
Harrisberger F, Smieskova R, Schmidt A, Lenz C, Walter A, Wittfeld
K, Grabe H, Lang U, Fusar-Poli P, Borgwardt S (2015) BDNF
Val66Met polymorphism and hippocampal volume in
neuropsychiatric disorders: a systematic review and meta-
analysis. Neurosci Biobehav Rev 55:107–118.
Hasanvand A, Amini-khoei H, Hadian M-R, Abdollahi A, Tavangar
SM, Dehpour AR, Semiei E, Mehr SE (2016) Anti-inﬂammatory
eﬀect of AMPK signaling pathway in rat model of diabetic
neuropathy. Inﬂammopharmacology 24:207–219.
Hassan AM, Jain P, Reichmann F, Mayerhofer R, Farzi A, Schuligoi
R, Holzer P (2014) Repeated predictable stress causes resilience
against colitis-induced behavioral changes in mice. Front Behav
Neurosci 8:386.
Heydarpour P, Rahimian R, Fakhfouri G, Khoshkish S, Fakhraei N,
Salehi-Sadaghiani M, Wang H, Abbasi A, Dehpour AR, Ghia J-E
(2016) Behavioral despair associated with a mouse model of
Crohn’s disease: role of nitric oxide pathway. Prog
Neuropsychopharmacol Biol Psychiatry 64:131–141.
Hollenbach E, Vieth M, Roessner A, Neumann M, Malfertheiner P,
Naumann M (2005) Inhibition of RICK/nuclear factor-jB and p38
signaling attenuates the inﬂammatory response in a murine model
of Crohn disease. J Biol Chem 280:14981–14988.
Hosseini M-J, Shaki F, Ghazi-Khansari M, Pourahmad J (2014)
Toxicity of copper on isolated liver mitochondria: impairment at
complexes I, II, and IV leads to increased ROS production. Cell
Biochem Biophys 70:367–381.
Hovatta I, Juhila J, Donner J (2010) Oxidative stress in anxiety and
comorbid disorders. Neurosci Res 68:261–275.
Irwin MR, Miller AH (2007) Depressive disorders and immunity: 20
years of progress and discovery. Brain Behav Immun
21:374–383.
Ito M, Ibi T, Sahashi K, Ichihara M, Ito M, Ohno K (2011) Open-label
trial and randomized, double-blind, placebo-controlled, crossover
trial of hydrogen-enriched water for mitochondrial and
inﬂammatory myopathies. Med Gas Res 1:24.
Jayakumar S, Kunwar A, Sandur SK, Pandey BN, Chaubey RC
(2014) Diﬀerential response of DU145 and PC3 prostate cancer
cells to ionizing radiation: role of reactive oxygen species, GSH
and Nrf2 in radiosensitivity. Biochim Biophys Acta (BBA)-Gen
Subj 1840:485–494.
Kennedy PJ, Cryan JF, Dinan TG, Clarke G (2014) Irritable bowel
syndrome: a microbiome-gut-brain axis disorder. World J
Gastroenterol 20:14105–14125.
136 A. Haj-Mirzaian et al. / Neuroscience 366 (2017) 124–137Khanavi M, Sabbagh-Bani-Azad M, Abdolghaﬀari AH, Vazirian M,
Isazadeh I, Rezvanfar MA, Baeeri M, Mohammadirad A, Rahimi
R, Shams-Ardekani MR (2014) On the beneﬁt of galls of Quercus
brantii Lindl. in murine colitis: the role of free gallic acid. Arch Med
Sci: AMS 10:1225.
Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A (2008) HMGB1:
endogenous danger signaling. Mol Med-Cambridge Ma Then New
York 14:476.
Kordjazy N, Haj-Mirzaian A, Amiri S, Ostadhadi S, Kordjazy M,
Sharifzadeh M, Dehpour AR (2015) Elevated level of nitric oxide
mediates the anti-depressant eﬀect of rubidium chloride in mice.
Eur J Pharmacol 762:411–418.
Ku¨hn R, Lo¨hler J, Rennick D, Rajewsky K, Mu¨ller W (1993)
Interleukin-10-deﬁcient mice develop chronic enterocolitis. Cell
75:263–274.
Kulesskaya N, Voikar V (2014) Assessment of mouse anxiety-like
behavior in the light–dark box and open-ﬁeld arena: role of
equipment and procedure. Physiol Behav 133:30–38.
Kurina L, Goldacre M, Yeates D, Gill L (2001) Depression and anxiety
in people with inﬂammatory bowel disease. J Epidemiol
Community Health 55:716–720.
Leppkes M, Roulis M, Neurath MF, Kollias G, Becker C (2014)
Pleiotropic functions of TNF-a in the regulation of the intestinal
epithelial response to inﬂammation. Int Immunol:dxu051.
Li J, Dong Y, Chen H, Han H, Yu Y, Wang G, Zeng Y, Xie K (2012)
Protective eﬀects of hydrogen-rich saline in a rat model of
permanent focal cerebral ischemia via reducing oxidative stress
and inﬂammatory cytokines. Brain Res 1486:103–111.
Lucas K, Maes M (2013) Role of the Toll Like receptor (TLR) radical
cycle in chronic inﬂammation: possible treatments targeting the
TLR4 pathway. Mol Neurobiol 48:190–204.
Mackner LM, Clough-Paabo E, Pajer K, Lourie A, Crandall WV (2011)
Psychoneuroimmunologic factors in inﬂammatory bowel disease.
Inﬂamm Bowel Dis 17:849–857.
Maes M (2008) The cytokine hypothesis of depression: inﬂammation,
oxidative & nitrosative stress (IO&NS) and leaky gut as new
targets for adjunctive treatments in depression. Neuro Endocrinol
Lett 29:287–291.
Maes M (2011) Depression is an inﬂammatory disease, but cell-
mediated immune activation is the key component of depression.
Prog Neuropsychopharmacol Biol Psychiatry 35:664–675.
Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera
M, Bob P, Lerer B, Maj M (2009) The inﬂammatory &
neurodegenerative (I&ND) hypothesis of depression: leads for
future research and new drug developments in depression. Metab
Brain Dis 24:27–53.
Maes M, Galecki P, Chang YS, Berk M (2011a) A review on the
oxidative and nitrosative stress (O&NS) pathways in major
depression and their possible contribution to the (neuro)
degenerative processes in that illness. Prog
Neuropsychopharmacol Biol Psychiatry 35:676–692.
Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J (2011b)
Depression’s multiple comorbidities explained by (neuro)
inﬂammatory and oxidative & nitrosative stress pathways.
Neuroendocrinol Lett 32:7–24.
Magalha˜es PV, Dean OM, Bush AI, Copolov DL, Malhi GS,
Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk
M (2011) N-acetylcysteine for major depressive episodes in
bipolar disorder. Revista brasileira de psiquiatria 33:374–378.
Magni G, Bernasconi G, Mauro P, D’odorico A, Sturniolo G, Canton
G, Martin A (1991) Psychiatric diagnoses in ulcerative colitis. A
controlled study. Br J Psychiatry 158:413–415.
Mancuso C, Scapagini G, Curro D, Giuﬀrida Stella AM, De Marco C,
Butterﬁeld DA, Calabrese V (2007) Mitochondrial dysfunction,
free radical generation and cellular stress response in
neurodegenerative disorders. Front Biosci 12:1107–1123.
Marrocco J, Reynaert M-L, Gatta E, Gabriel C, Mocae¨r E, Di Prisco S,
Merega E, Pittaluga A, Nicoletti F, Maccari S (2014) The eﬀects of
antidepressant treatment in prenatally stressed rats support the
glutamatergic hypothesis of stress-related disorders. J Neurosci
34:2015–2024.Martin-Subero M, Anderson G, Kanchanatawan B, Berk M, Maes M
(2015) Comorbidity between depression and inﬂammatory bowel
disease explained by immune-inﬂammatory, oxidative, and
nitrosative stress; tryptophan catabolite; and gut–brain
pathways. CNS Spectr:1–15.
Mayer EA, Padua D, Tillisch K (2014a) Altered brain-gut axis in
autism: comorbidity or causative mechanisms? BioEssays
36:933–939.
Mayer EA, Savidge T, Shulman RJ (2014b) Brain–gut microbiome
interactions and functional bowel disorders. Gastroenterology
146:1500–1512.
McCusker RH, Kelley KW (2013) Immune–neural connections: how
the immune system’s response to infectious agents inﬂuences
behavior. J Exp Biol 216:84–98.
Mikocka-Walus A, Pittet V, Rossel J-B, von Ka¨nel R, Group SICS
(2016) Symptoms of depression and anxiety are independently
associated with clinical recurrence of inﬂammatory bowel disease.
Clin Gastroenterol Hepatol.
Morris G, Maes M (2014) Mitochondrial dysfunctions in myalgic
encephalomyelitis/chronic fatigue syndrome explained by
activated immuno-inﬂammatory, oxidative and nitrosative stress
pathways. Metab Brain Dis 29:19–36.
Mudaliar H, Pollock C, Komala MG, Chadban S, Wu H,
Panchapakesan U (2013) The role of Toll-like receptor proteins
(TLR) 2 and 4 in mediating inﬂammation in proximal tubules. Am J
Physiol-Renal Physiol 305:F143–F154.
Neurath MF (2014) Cytokines in inﬂammatory bowel disease. Nat
Rev Immunol 14:329–342.
Neurath M, Fuss I, Strober W (2000) TNBS-colitis. Int Rev Immunol
19:51–62.
Nyuyki-Dufe K, Cluny NL, Sharkey KA, Swain MG, Pittman QJ (2016)
Behavioral comorbidities in dextran sulphate sodium (DSS) colitis,
an animal model of inﬂammatory bowel diseases. FASEB J 30:
lb637.
Obermeier F, Kojouharoﬀ G, Hans W, Scho¨lmerich J, Gross V, Falk
W (1999) Interferon-gamma (IFN-c)-and tumour necrosis factor
(TNF)-induced nitric oxide as toxic eﬀector molecule in chronic
dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp
Immunol 116:238.
Ohland CL, Kish L, Bell H, Thiesen A, Hotte N, Pankiv E, Madsen KL
(2013) Eﬀects of Lactobacillus helveticus on murine behavior are
dependent on diet and genotype and correlate with alterations in
the gut microbiome. Psychoneuroendocrinology 38:1738–1747.
Ohno K, Ito M, Ichihara M (2012) Ito M (2012) Molecular hydrogen as
an emerging therapeutic medical gas for neurodegenerative and
other diseases. Oxid Med Cell Longevity.
Papadakis KA, Targan SR (2000) Role of cytokines in the
pathogenesis of inﬂammatory bowel disease. Annu Rev Med
51:289–298.
Park S-J, Lee M-Y, Son B-S, Youn H-S (2009) TBK1-targeted
suppression of TRIF-dependent signaling pathway of Toll-like
receptors by 6-shogaol, an active component of ginger. Biosci
Biotechnol Biochem 73:1474–1478.
Patki G, Solanki N, Atrooz F, Allam F, Salim S (2013) Depression,
anxiety-like behavior and memory impairment are associated with
increased oxidative stress and inﬂammation in a rat model of
social stress. Brain Res 1539:73–86.
Pellissier S, Dantzer C, Mondillon L, Trocme C, Gauchez A-S, Ducros
V, Mathieu N, Toussaint B, Fournier A, Canini F (2014)
Relationship between vagal tone, cortisol, TNF-alpha,
epinephrine and negative aﬀects in Crohn’s disease and irritable
bowel syndrome. PLoS ONE 9:e105328.
Petit A-C, Quesseveur G, Gressier F, Colle R, David DJ, Gardier AM,
Ferreri F, Le´pine J-P, Falissard B, Verstuyft C (2014) Converging
translational evidence for the involvement of the serotonin 2A
receptor gene in major depressive disorder. Prog
Neuropsychopharmacol Biol Psychiatry 54:76–82.
Porsolt R, Bertin A, Jalfre M (1977) Behavioral despair in mice: a
primary screening test for antidepressants. Arch Int Pharm The´r
229:327–336.
A. Haj-Mirzaian et al. / Neuroscience 366 (2017) 124–137 137Reichmann F, Hassan AM, Farzi A, Jain P, Schuligoi R, Holzer P
(2015) Dextran sulfate sodium-induced colitis alters stress-
associated behaviour and neuropeptide gene expression in the
amygdala-hippocampus network of mice. Sci Rep 5.
Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL (2009)
Mitochondrial dysfunction and psychiatric disorders. Neurochem
Res 34:1021–1029.
Riazi K, Galic MA, Kuzmiski JB, Ho W, Sharkey KA, Pittman QJ
(2008) Microglial activation and TNFa production mediate altered
CNS excitability following peripheral inﬂammation. Proc Natl Acad
Sci 105:17151–17156.
Rohan Walker F, Nilsson M, Jones K (2013) Acute and chronic
stress-induced disturbances of microglial plasticity, phenotype
and function. Curr Drug Targets 14:1262–1276.
Rossignol DA, Frye RE (2015) Mitochondrial dysfunction in
psychiatric disorders. In: Studies on psychiatric
disorders. Springer. p. 231–244.
Senhaji N, Serrano A, Badre W, Serbati N, Karkouri M, Zaid Y, Nadiﬁ
S, Martin J (2016) Association of inﬂammatory cytokine gene
polymorphisms with inﬂammatory bowel disease in a Moroccan
cohort. Genes Immun 17:60–65.
Severance EG, Yolken RH, Eaton WW (2014) Autoimmune diseases,
gastrointestinal disorders and the microbiome in schizophrenia:
more than a gut feeling. Schizophr Res.
Singhal G, Jaehne EJ, Corrigan F, Toben C, Baune BT (2014)
Inﬂammasomes in neuroinﬂammation and changes in brain
function: a focused review. Front Neurosci 8.
Slavich GM, Irwin MR (2014) From stress to inﬂammation and major
depressive disorder: a social signal transduction theory of
depression. Psychol Bull 140:774.
Sonei N, Amiri S, Jafarian I, Anoush M, Rahimi-Balaei M, Bergen H,
Haj-Mirzaian A, Hosseini M-J (2017) Mitochondrial dysfunction
bridges negative aﬀective disorders and cardiomyopathy in
socially isolated rats: pros and cons of ﬂuoxetine. World J Biol
Psychiatry 18:39–53.
Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension
test: a new method for screening antidepressants in mice.
Psychopharmacology 85:367–370.
Strober W, Fuss IJ (2011) Proinﬂammatory cytokines in the
pathogenesis of inﬂammatory bowel diseases. Gastroenterology
140(1756–1767):e1751.
Sun Y, Cai T-T, Shen Y, Zhou X-B, Chen T, Xu Q (2009) Si-Ni-San, a
traditional Chinese prescription, and its active ingredient
glycyrrhizin ameliorate experimental colitis through regulating
cytokine balance. Int Immunopharmacol 9:1437–1443.
Tache´ Y, Bernstein CN (2009) Evidence for the role of the brain-gut
axis in inﬂammatory bowel disease: depression as cause and
eﬀect? Gastroenterology 136:2058.
Taft TH, Keefer L (2016) A systematic review of disease-related
stigmatization in patients living with inﬂammatory bowel disease.
Clin Exp Gastroenterol 9:49.
Takeda H, Tsuji M, Matsumiya T (1998) Changes in head-dipping
behavior in the hole-board test reﬂect the anxiogenic and/or
anxiolytic state in mice. Eur J Pharmacol 350:21–29.
Tirosh O, Levy E, Reifen R (2007) High selenium diet protects against
TNBS-induced acute inﬂammation, mitochondrial dysfunction,
and secondary necrosis in rat colon. Nutrition 23:878–886.
Tobe EH (2013) Mitochondrial dysfunction, oxidative stress, and
major depressive disorder. Neuropsychiatr Dis Treat 9:567–573.
Triantaﬁllidis JK, Merikas E, Gikas A (2013) Psychological factors
and stress in inﬂammatory bowel disease. Expert Rev
Gastroenterol Hepatol 7:225–238.Ung VY, Foshaug RR, MacFarlane SM, Churchill TA, Doyle JS,
Sydora BC, Fedorak RN (2010) Oral administration of curcumin
emulsiﬁed in carboxymethyl cellulose has a potent anti-
inﬂammatory eﬀect in the IL-10 gene-deﬁcient mouse model of
IBD. Dig Dis Sci 55:1272–1277.
van den Brink G, Stapersma L, El Marroun H, Henrichs J, Szigethy
EM, Utens EM, Escher JC (2016) Eﬀectiveness of disease-
speciﬁc cognitive–behavioural therapy on depression, anxiety,
quality of life and the clinical course of disease in adolescents with
inﬂammatory bowel disease: study protocol of a multicentre
randomised controlled trial (HAPPY-IBD). BMJ Open
Gastroenterol 3.
Vutskits L, Djebbara-Hannas Z, Zhang H, Paccaud JP, Durbec P,
Rougon G, Muller D, Kiss JZ (2001) PSA-NCAM modulates
BDNF-dependent survival and diﬀerentiation of cortical neurons.
Eur J Neurosci 13:1391–1402.
Waldner MJ, Neurath MF (2014) Master regulator of intestinal
disease: IL-6 in chronic inﬂammation and cancer development.
Seminars in immunology, vol. 26. Elsevier. p. 75–79.
Wallace DL, Han M-H, Graham DL, Green TA, Vialou V, Iniguez SD,
Cao J-L, Kirk A, Chakravarty S, Kumar A (2009) CREB regulation
of nucleus accumbens excitability mediates social isolation–
induced behavioral deﬁcits. Nat Neurosci 12:200–209.
Weber MD, Frank MG, Tracey KJ, Watkins LR, Maier SF (2015)
Stress induces the danger-associated molecular pattern HMGB-1
in the hippocampus of male sprague dawley rats: a priming
stimulus of microglia and the NLRP3 inﬂammasome. J Neurosci
35:316–324.
Wieckowski MR, Giorgi C, Lebiedzinska M, Duszynski J, Pinton P
(2009) Isolation of mitochondria-associated membranes and
mitochondria from animal tissues and cells. Nat Protoc 4:1582.
Wohleb ES (2013) Stress-induced monocyte re-distribution and
microglia activation underlies development and recurrence of
anxiety. The Ohio State University.
Wu T-Y, Liu L, Zhang W, Zhang Y, Liu Y-Z, Shen X-L, Gong H, Yang
Y-Y, Bi X-Y, Jiang C-L (2015) High-mobility group box-1 was
released actively and involved in LPS induced depressive-like
behavior. J Psychiatr Res 64:99–106.
Xie K, Yu Y, Huang Y, Zheng L, Li J, Chen H, Han H, Hou L, Gong G,
Wang G (2012) Molecular hydrogen ameliorates
lipopolysaccharide-induced acute lung injury in mice through
reducing inﬂammation and apoptosis. Shock 37:548–555.
Xu Y, Ku B-S, Yao H-Y, Lin Y-H, Ma X, Zhang Y-H, Li X-J (2005)
Antidepressant eﬀects of curcumin in the forced swim test and
olfactory bulbectomy models of depression in rats. Pharmacol
Biochem Behav 82:200–206.
Yanartas O, Kani H, Bicakci E, Kilic I, Banzragch M, Acikel C, Atug O,
Kuscu K, Imeryuz N, Akin H (2016) The eﬀects of psychiatric
treatment on depression, anxiety, quality of life, and sexual
dysfunction in patients with inﬂammatory bowel disease.
Neuropsychiatr Dis Treat 12:673.
Youn HS, Lee JY, Saitoh SI, Miyake K, Kang KW, Choi YJ, Hwang
DH (2006) Suppression of MyD88-and TRIF-dependent signaling
pathways of Toll-like receptor by ()-epigallocatechin-3-gallate, a
polyphenol component of green tea. Biochem Pharmacol
72:850–859.
Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ,
Tracey KJ, Yang H (2006) HMGB1 signals through toll-like
receptor (TLR) 4 and TLR2. Shock 26:174–179.
Zhao Z, Wang W, Guo H, Zhou D (2008) Antidepressant-like eﬀect of
liquiritin from Glycyrrhiza uralensis in chronic variable stress
induced depression model rats. Behav Brain Res 194:108–113.(Received 28 June 2017, Accepted 16 October 2017)
(Available online 26 October 2017)
